AADC Gene Therapy for Parkinson's Disease
A Phase I /II Study of Intra-putaminal Infusion of Adeno-Associated Virus Encoding Human Aromatic L-Amino Acid Decarboxylase in Subjects With Parkinson's Disease
Sponsor: Gene Therapy Research Institution,Co.,Ltd.
Terminated
another clinical study for regulatory approval is planned
Other Parkinson Disease trials with similar outcome
A PHASE1/PHASE2 clinical study on Parkinson Disease, this trial is terminated or withdrawn. The trial is conducted by Gene Therapy Research Institution,Co.,Ltd. and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
-
Sep 2019 — Jan 2021 [monthly]
Terminated PHASE1_PHASE2
Status: Recruiting → Terminated
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gene Therapy Research Institution,Co.,Ltd.
- Jichi Medical University
- Takara Bio Inc.
For direct contact, visit the study record on ClinicalTrials.gov .